Abstract
Purpose
Fear of cancer recurrence (FCR) is one of the most common and distressing issues affecting cancer survivors. This study examined (1) the association between modifiable cognitive, behavioral, and social characteristics and FCR, (2) the association between non-modifiable characteristics and FCR, and (3) the relative contributions of modifiable and non-modifiable characteristics to FCR.
Methods
Participants (n = 120) had been diagnosed with colorectal cancer and completed cancer treatment in the past 6 to 36 months. Participants completed self-report measures of modifiable cognitive (e.g., beliefs about worry), behavioral (e.g., health-related reassurance seeking), and social (e.g., social constraints) characteristics. Non-modifiable characteristics (e.g., age, disease severity) were assessed via self-report and medical record review.
Findings
Modifiable (i.e., perceived risk, self-efficacy, positive beliefs about worry, negative beliefs about worry, intolerance of uncertainty, rumination, reassurance seeking, health-related reassurance seeking, social constraints) and non-modifiable (i.e., age, gender, disease severity, neuroticism, conscientiousness) characteristics were associated with FCR (p’s < .05). Hierarchical linear regression analyses demonstrated that modifiable characteristics accounted for an additional 15% of the variance (p < .001) beyond that accounted for by non-modifiable characteristics (R2 = .45, p < .001), with perceived risk (B = .35) and health-related reassurance seeking (B = .22) emerging as significant predictors of FCR (p’s < .05).
Implications
Results identify non-modifiable characteristics that may serve as risk factors for greater FCR and identify specific modifiable characteristics (i.e., perceived risk, health-related reassurance seeking) to be targeted by interventions to reduce FCR among cancer survivors.
Similar content being viewed by others
References
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322
Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J et al (2016) From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24(8):3265–3268. https://doi.org/10.1007/s00520-016-3272-5
Koch L, Jansen L, Brenner H, Arndt V (2013) Fear of cancer recurrence and disease progression in long-term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psycho-Oncology 22:1–11
Otto AK, Soriano EC, Siegel SD, LoSavio ST, Laurenceau J-P (2018) Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors. J Cancer Surviv 12(6):775–785. https://doi.org/10.1007/s11764-018-0714-8
Lebel S, Tomei C, Feldstain A, Beattie S, McCallum M (2013) Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer 21:901–906
Maheu C, Galica J (2018) The fear of cancer recurrence literature continues to move forward: a review article. Curr Opin Support Palliat Care 12(1):40–45. https://doi.org/10.1097/SPC.0000000000000323
Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith AB, Girgis A, Butow (2016) Fear of cancer recurrence: a theoretical review and novel processing formulation. J Cancer Surviv 10:663–673
Dugas MJ, Marchand A, Ladouceur R (2005) Further validation of a cognitive- behavioral model of generalized anxiety disorder: diagnostic and symptom specificity. J Anxiety Disord 19:329–343
Langlois F, Ladouceur R (2004) Treatment for hypochondriasis. Cogn Behav Pract 11:393–404
Abramowitz JS, Schwartz SA, Whiteside SP (2002) A contemporary conceptual model of hypochondriasis. Mayo Clin Proc 77(12):1323–1330. https://doi.org/10.4065/77.12.1323
Melchior H, Buscher C, Thorenz A, Grochocka A, Koch U, Watzke B (2013) Self- efficacy and fear of cancer progression during the year following diagnosis of breast cancer. Psycho-oncology 22:39–45
Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Heckman C, Rosenblum N, Morgan M, Graff JJ (2013) Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers. Gynecol Oncol 128:120–127
Thewes B, Bell ML, Butow P (2013) Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psycho-Oncology 22(9):2059–2063. https://doi.org/10.1002/pon.3252
Crist JV, Grunfeld EA (2013) Factors reported to influence fear of cancer recurrence in cancer patients: a systematic review. Psycho-Oncology 22:978–986
Soriano EC, Pasipanodya EC, LoSavio ST et al (2018) Social constraints and fear of recurrence in couples coping with early stage breast cancer. Health Psychol 37(9):874–884. https://doi.org/10.1037/hea0000649
Lepore SJ, Revenson TA (2007) Social constraints on disclosure and adjustment to cancer. Soc Personal Psychol Compass 1:313–333
Savard J, Ivers H (2013) The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 74:354–360
Simard S, Savard J, Ivers H (2010) Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv 4(4):361–371. https://doi.org/10.1007/s11764-010-0136-8
Llewellyn CD, Weinman J, McGurk M, Humphris G (2008) Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res 65(6):525–532. https://doi.org/10.1016/j.jpsychores.2008.03.014
Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V (2016) Fear of recurrence in long-term cancer survivors—do cancer type, sex, time since diagnosis, and social support matter? Health Psychol 35(12):1329–1333. https://doi.org/10.1037/hea0000374
Allemand M, Steiger AE, Hill PL (2013) Stability of personality traits in adulthood: mechanisms and implications. GeroPsych 26(1):5–13. https://doi.org/10.1024/1662-9647/a000080
Lahey BB (2009) Public health significance of neuroticism. Am Psychol 64:241–256
Sher KJ, Rossy L, Bishop AK (2000) Distinguishing manifestations of anxiety: how do personality traits of compulsive checkers differ from other anxious individuals? Behav Res Ther 38:229–241
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193. https://doi.org/10.3322/caac.21395
Taylor C, Richardson A, Cowley S (2011) Surviving cancer treatment: an investigation of the experience of fear about, and monitoring for, recurrence in patients following treatment for colorectal cancer. Eur J Oncol Nurs 15:243–249
Custers JAE, Gielissen MFM, Janssen SHV, de Wilt JHW, Prins JB (2016) Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer 24:555–562. https://doi.org/10.1007/s00520-015-2808-4
Valdimarsdottir HB, Bovbjerg DH, Kash KM, Holland JC, Osborne MP, Miller DG (1995) Psychological distress in women with a familial risk of breast cancer. Psycho-Oncology 4(2):133–141
McGinty HL, Small BJ, Laronga C, Jacobsen PB (2016) Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol 35:1–9
Clark NM, Dodge JA (1999) Exploring self-efficacy as a predictor of disease management. Health Educ Behav 26:72–89
Wells A, Cartwright-Hatton S (2004) A short form of the metacognitions questionnaire: properties of the MCQ-30. Behav Res Ther 42:385–396
Longley SL, Watson D, Noyes R (2005) Assessment of the hypochondriasis domain: the multidimensional inventory of hypochondriacal traits (MIHT). Psychol Assess 17:3–14
Buhr K, Dugas MJ (2002) The intolerance of uncertainty scale: psychometric properties of the English version. Behav Res Ther 40:931–945
Trapnell PD, Campbell JD (1999) Private self-consciousness and the five-factor model of personality: distinguishing rumination from reflection. J Pers Soc Psychol 76:284–304
Cougle JR, Fitch KE, Fincham FD, Riccardi CJ, Keough ME, Timpano KR (2012) Excessive reassurance seeking and anxiety pathology: tests of incremental associations and directionality. J Anxiety Disord 26:117–125
Cohen S (2008) Basic psychometrics for the ISEL-12. Retrieved from http://www.psy.cmu.edu/~scohen/scales.html
Lepore SJ, Silver RC, Wortman CB, Wayment HA (1996) Social constraints, intrusive thoughts and depressive symptoms among bereaved mothers. J Pers Soc Psychol 70:271–282
McCrae RR, Costa PT (2004) A contemplated revision of the NEO Five-Factor Inventory. Personal Individ Differ 36:587–596
Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 17:241–251
Simard S, Savard J (2015) Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 9(3):481–491
Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, Tiller K, Simard S, Feldstain A, Beattie S, McCallum M, on behalf of the Conquer Fear authorship group, Butow P (2018) Exploring the screening capacity of the fear of cancer recurrence inventory-short form for clinical levels of fear of cancer recurrence. Psycho-Oncology 27(2):492–499. https://doi.org/10.1002/pon.4516
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*power 3: a flexible statistical power analysis program for the social behavioral and biomedical sciences. Behav Res Methods 39:175–191
Custers JAE, Gielissen MFM, de Wilt JHW, Honkoop A, Smilde TJ, van Spronsen D-J, van der Veld W, van der Graaf WTA, Prins JB (2017) Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors. J Cancer Surviv 11(1):41–47. https://doi.org/10.1007/s11764-016-0558-z
Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, McLachlan SA, Members of the FCR Study Advisory Committee (2013) Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psycho-oncology 22:2797–2806
Liao KY, Yeung NC, Wong CC, Warmoth K, Lu Q (2017) Fear of cancer recurrence and physical well-being among Chinese cancer survivors: the role of conscientiousness, positive reappraisal and hopelessness. Support Care Cancer 25:1141–1149
Bogg T, Roberts BW (2004) Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychol Bull 130(6):887–919. https://doi.org/10.1037/0033-2909.130.6.887
Butow P, Kelly S, Thewes B, Hruby G, Sharpe L, Beith J (2015) Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psycho-Oncology 24:416–423
Smith A“B”, Sharpe L, Thewes B, Turner J, Gilchrist J, Fardell JE et al (2018) Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study. Support Care Cancer. https://doi.org/10.1007/s00520-018-4294-y
Mullens AB, McCaul KD, Erickson SC, Sandgren AK (2004) Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors. Psycho-Oncology 13(6):367–376. https://doi.org/10.1002/pon.751
Kim SE, Pérez-Stable EJ, Wong S, Gregorich S, Sawaya GF, Walsh JME, Kaplan CP (2008) Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med 168(7):728–734. https://doi.org/10.1001/archinte.168.7.728
Lipkus IM, Skinner CS, Green LSG, Dement J, Samsa GP, Ransohoff D (2004) Modifying attributions of colorectal cancer risk. Cancer Epidemiol Biomark Prev 13(4):560–566
Robb KA, Campbell J, Evans P, Miles A, Wardle J (2008) Impact of risk information on perceived colorectal cancer risk: a randomized trial. J Health Psychol 13(6):744–753. https://doi.org/10.1177/1359105308093858
Colorectal Cancer Risk Assessment Tool (n.d.) Retrieved April 23, 2019, from Colorectal Cancer Risk Assessment Tool website: https://www.cancer.gov/ccrisktool
Weck F, Neng JMB, Richtberg S, Jakob M, Stangier U (2015) Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): a randomized controlled trial. J Consult Clin Psychol 83(4):665–676. https://doi.org/10.1037/ccp0000013
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Jim reported other from RedHill Biopharma, other from Janssen Scientific Affairs, other from Merck, outside the submitted work. The views expressed are those of the authors and do not necessarily represent those of the National Cancer Institute.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cessna Palas, J.M., Hyland, K.A., Nelson, A.M. et al. An examination of the relationship of patient modifiable and non-modifiable characteristics with fear of cancer recurrence among colorectal cancer survivors. Support Care Cancer 29, 869–876 (2021). https://doi.org/10.1007/s00520-020-05552-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-020-05552-4